Your browser doesn't support javascript.
loading
Quinolone and Multidrug Resistance Predicts Failure of Antibiotic Prophylaxis of Spontaneous Bacterial Peritonitis.
Mücke, Marcus M; Mayer, Amelie; Kessel, Johanna; Mücke, Victoria T; Bon, Dimitra; Schwarzkopf, Katharina; Rüschenbaum, Sabrina; Queck, Alexander; Göttig, Stephan; Vermehren, Annika; Weiler, Nina; Welker, Martin-Walter; Reinheimer, Claudia; Hogardt, Michael; Vermehren, Johannes; Herrmann, Eva; Kempf, Volkhard A J; Zeuzem, Stefan; Lange, Christian M.
Afiliação
  • Mücke MM; Department of Internal Medicine 1, University Hospital Frankfurt, Frankfurt am Main, Germany.
  • Mayer A; University Center for Infectious Diseases, University Hospital Frankfurt, Frankfurt am Main, Germany.
  • Kessel J; Department of Internal Medicine 1, University Hospital Frankfurt, Frankfurt am Main, Germany.
  • Mücke VT; University Center for Infectious Diseases, University Hospital Frankfurt, Frankfurt am Main, Germany.
  • Bon D; Department of Internal Medicine 2, University Hospital Frankfurt, Frankfurt am Main, Germany.
  • Schwarzkopf K; Department of Internal Medicine 1, University Hospital Frankfurt, Frankfurt am Main, Germany.
  • Rüschenbaum S; University Center for Infectious Diseases, University Hospital Frankfurt, Frankfurt am Main, Germany.
  • Queck A; Institute of Biostatistics and Mathematical Modeling, Goethe University Frankfurt, Frankfurt am Main, Germany.
  • Göttig S; Department of Internal Medicine 1, University Hospital Frankfurt, Frankfurt am Main, Germany.
  • Vermehren A; Department of Internal Medicine 1, University Hospital Frankfurt, Frankfurt am Main, Germany.
  • Weiler N; Department of Internal Medicine 1, University Hospital Frankfurt, Frankfurt am Main, Germany.
  • Welker MW; University Center for Infectious Diseases, University Hospital Frankfurt, Frankfurt am Main, Germany.
  • Reinheimer C; Institute of Medical Microbiology and Infection Control, University Hospital Frankfurt, Frankfurt am Main, Germany.
  • Hogardt M; Department of Internal Medicine 1, University Hospital Frankfurt, Frankfurt am Main, Germany.
  • Vermehren J; Department of Internal Medicine 1, University Hospital Frankfurt, Frankfurt am Main, Germany.
  • Herrmann E; Department of Internal Medicine 1, University Hospital Frankfurt, Frankfurt am Main, Germany.
  • Kempf VAJ; University Center for Infectious Diseases, University Hospital Frankfurt, Frankfurt am Main, Germany.
  • Zeuzem S; Institute of Medical Microbiology and Infection Control, University Hospital Frankfurt, Frankfurt am Main, Germany.
  • Lange CM; University Center for Infectious Diseases, University Hospital Frankfurt, Frankfurt am Main, Germany.
Clin Infect Dis ; 70(9): 1916-1924, 2020 04 15.
Article em En | MEDLINE | ID: mdl-31228250
ABSTRACT

BACKGROUND:

The efficacy of antibiotic prophylaxis to prevent spontaneous bacterial peritonitis (SBP) in patients colonized with multidrug-resistant organisms (MDROs) is unknown. We evaluated the effectiveness of fluoroquinolone-based SBP prophylaxis in an era and area of frequent antibiotic resistance.

METHODS:

This is a prospective observational study in patients with liver cirrhosis and an indication for fluoroquinolone-based prophylaxis of SBP. Patients were recruited and followed in a large German tertiary reference center with comprehensive microbiological and clinical monitoring performed at baseline and after 30, 60, 90, and 180 days of prophylaxis.

RESULTS:

Overall, 77 patients received antibiotic prophylaxis for an average of 93 days. Baseline prevalence of colonization with MDROs was high (N = 39, 50.6%). At least one de novo MDRO was detected in 27 patients (35.1%) during antibiotic prophylaxis; 33 patients (42.9%) developed secondary infections, including 14 cases (17.9%) of infections with MDROs, and 13 cases (16.9%) of de novo/recurrent SBP. Thirty patients (39.0%) died during follow-up. Significantly higher risks of SBP development during antibiotic prophylaxis were observed for patients with versus without any apparent MDROs (P = .009), vancomycin-resistant enterococci (P = .008), multidrug-resistant gram-negative bacteria (P = .016), or quinolone-resistant gram-negative bacteria (QR-GNB) (P = .015). In competing risk analysis, QR-GNB were independently associated with prophylaxis failure (hazard ratio, 3.39; P = .045) and infections with QR-GNB were independently associated with death before SBP (subdistribution hazard risk, 6.47; P = .034).

CONCLUSIONS:

Antibiotic prophylaxis of SBP appears to be less efficient in patients with known MDROs. Regular MDRO screening seems to be useful to tailor treatment of secondary infections and re-evaluate antibiotic prophylaxis in case of selection of quinolone resistance.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Peritonite / Infecções Bacterianas / Quinolonas Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Peritonite / Infecções Bacterianas / Quinolonas Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article